Skip to content
Kovina Therapeutics logo — Kovina Therapeutics is a preclinical stage biotechnology com...

Kovina Therapeutics

Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral HPV therapeutics

Founded 2020 5 employees Grant Total: $2.58M Biotechnology, Health and Wellness

General Information

Company Name Kovina Therapeutics
Founded Year 2020
Employees 5
Industries Biotechnology, Health and Wellness
Funding Stage Grant
Social

BounceWatch is an independent company data service, not affiliated with Kovina Therapeutics. To contact Kovina Therapeutics, visit kovina.com.

Is this your company?

Confirm with your work e-mail, get the Verified badge and keep this profile correct yourself. Search engines and AI assistants read it every day.

Get Verified

How does Kovina Therapeutics compare?

A PDF of Kovina Therapeutics and up to 10 competitors you pick: team, funding, traffic and every dated move of the last 90 days. Each company is re-checked on the day you order, so it is current.

See a sample report

This takes a few seconds: we look beyond our own index too.

Meeting Kovina Therapeutics soon?

A one-page PDF brief: what it does, key facts, the last 90 days of dated moves and questions worth asking. Re-checked on the day you order. See a sample

About Kovina Therapeutics

Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral HPV therapeutics. The company, founded in 2020, aims to treat cancers and pre-malignant infections caused by Human Papillomavirus (HPV). Their efforts focus on the Biotechnology and Health and Wellness industries. In November 2022, they received a $275.00K grant investment from the National Institute of Dental and Craniofacial Research (NIDCR).

Business keywords: preclinical stage, antiviral therapeutics, cancer treatment, HPV, non-surgical treatment, medical research, oncology, pharmaceuticals, viral infections

Funding Rounds & Investors (4)

View All
Funding Stage Amount Investors Lead Investors Date
Grant $275.00K 1
National Institute of Dental and Craniofacial Research (NIDCR)
01 Nov 2022
Grant $300.00K 1
National Institute of Allergy and Infectious Diseases
12 Sep 2022
Grant Undisclosed 1
National Cancer Institute
27 Jun 2022
Seed Round $2.00M 3
IU Ventures, Elevate Ventures +1
20 Oct 2021

Kovina Therapeutics Alternatives & Competitors

View All Alternatives
Kovina Therapeutics vs
Antios Therapeutics
Antios Therapeutics United States

Antios Therapeutics is a clinical-stage biopharmaceutical company devoted to developing therapies fo...

1 employees
Biopharma, Biotechnology
Kovina Therapeutics vs

Clinical stage biopharmaceutical company spearheading antiviral drug innovation

Debt Financing
14 employees
Biopharma, Biotechnology
Kovina Therapeutics vs

A preclinical stage company focused on subverting cancer's ability to evade therapy.

Series A
6 employees
Biotechnology, Health Care

FAQ About Kovina Therapeutics

Kovina Therapeutics is a preclinical stage biotechnology company developing first-in-class antiviral HPV therapeutics
Kovina Therapeutics was founded in 2020.
Kovina Therapeutics operates in Biotechnology and Health and Wellness. Its work centres on preclinical stage, antiviral therapeutics, cancer treatment and HPV.
Kovina Therapeutics has approximately 5 employees.
Kovina Therapeutics has completed 4 funding rounds, raising a total of $2.58M. The latest funding stage is Grant.
Top alternatives and competitors to Kovina Therapeutics include Antios Therapeutics, Atriva Therapeutics GmbH, Kurome Therapeutics, Inc., Via Nova Therapeutics, Treadwell Therapeutics, Inc.. These companies operate in related industries and serve comparable markets. You can compare them side by side on Bounce Watch.
Kovina Therapeutics and Antios Therapeutics are both companies in similar industries. Compare their funding, team size, growth signals, and market position on Bounce Watch to see which one fits your needs.

Source: BounceWatch company record for Kovina Therapeutics, https://bouncewatch.com/company/kovina-therapeutics, updated 20 December 2024. When citing, please name BounceWatch and link this page.

Analytics cookies (ours + Google). Cookie Policy

Talk to an analyst Book a 7-day Readout